An announcement that the state of Virginia will follow guidance from the U.S. Food and Drug Administration and pause use of the Johnson & Johnson COVID-19 vaccine won’t impact many Henricoans, at least initially. In a statement early Tuesday, FDA officials recommended the pause “out of an abundance of caution” while they investigate six cases of rare blood clots in women who received the vaccine. The women, between the ages of 18 and 48, developed the clots between 6 and 13 days after receiving the vaccine. One (possibly a Virginia resident, according to state vaccination coordinator Danny Avula) died, and...